Ohsu Knight Cancer Institute
Clinical trials sponsored by Ohsu Knight Cancer Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New scan may find hidden prostate cancer when standard test fails Results expected Dec 2026 (estimated)
- New combo therapy targets tough lymphoma in early trial Results expected Dec 2026 (estimated)
- Oregon launches massive melanoma awareness push – 75,000 people enrolled Results expected Dec 2026 (estimated)
- No-Scope cancer screening could save lives in rural oregon Results expected Dec 2026 (estimated)
- Fiber supplements may alter gut bacteria linked to colon cancer risk Results expected Dec 2026 (estimated)
-
New chemo combo targets Hard-to-Treat liver cancer
Disease control Stopped earlyThis early-phase trial tested a two-step chemotherapy approach for people with a type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be surgically removed. First, patients received a standard chemo mix (mFOLFIRINOX) through the veins. Then, they got a second chemo …
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Tailored cancer therapy put to the test
Disease control Stopped earlyThis study tested a precision medicine approach for people with advanced cancers like breast, ovarian, pancreatic, prostate, or sarcoma. Researchers used genetic and protein tests to track how the cancer changes and then a team of experts recommended personalized drugs. The goal …
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can smartphone cameras spot skin cancer as well as a dermatologist?
Diagnosis Stopped earlyThis study tested three portable imaging systems (MoleMapper, Visiomed, and confocal microscopy) to see how well they could detect melanoma compared to a dermatologist's exam. Seventeen people with suspicious moles participated. The goal was to find out if these devices could acc…
Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
AI mole checker tested at home – but trial stops early
Diagnosis Stopped earlyThis study tested whether a device called the Sklip System, which uses artificial intelligence, could help people at home decide if a mole might be skin cancer. Only one person took part before the study was stopped early. The goal was to see if the AI could match or beat standar…
Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New MRI technique aims to solve brain tumor treatment mystery
Diagnosis Stopped earlyThis pilot study tested whether a special MRI using ferumoxytol (an iron-based contrast agent) can better distinguish true tumor growth from treatment-related inflammation (pseudoprogression) in people with glioblastoma receiving the immunotherapy drug pembrolizumab. The study en…
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated Jun 26, 2026 15:10 UTC